Search
Biotech CEO Sisterhood: Vir's CEO Marianne De Backer describes her background and leadership style, and joining Vir as it experienced a road bump, but turning it into an opportunity via a key IO deal
Interviewed by Sisterhood editorial board member Grace Colón, Marianne De Backer advocates for the importance of getting experience in a...
Mar 3
The Liver Meeting: Vir Biotechnology presented data from programs for chronic hepatitis B and chronic hepatitis delta
Vir Chief Medical Officer Mark Eisner discusses the MARCH Phase 2 study results for hepaitis B, and Hôpital Beaujon Professor of...
Nov 21, 2024
Marianne De Backer talks about joining Vir Biotechnology and shares her vision for the future
Vir's new CEO gives an overview of the company's programs and discusses future plans to expand into autoimmune disease and oncology.
Dec 5, 2023
.png){kind=logo}
